• Statement from the IOM Council on Vaccine Development (2001)
  • An Assessment of the Safety of the Anthrax Vaccine: A Letter Report (2000)
  • Calling the Shots: Immunization Finance Policies and Practices (2000)
  • Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine Availability: A Letter Report (2000)
  • Vaccines for the 21st Century: A Tool for Decisionmaking (2000)
  • Assessment of Future Scientific Needs for Live Variola Virus (1999)
  • Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices (1999)
  • Detecting and Responding to Adverse Events Following Vaccination: Workshop Summary (1997)
  • Research to Identify Risks for Adverse Events Following Vaccination: Biological Mechanisms and Possible Means of Prevention: Workshop Summary (1997)
  • Risk Communication and Vaccination: Workshop Summary (1997)
  • Options for Poliomyelitis Vaccination in the United States: Workshop Summary (1996)
  • Vaccines Against Malaria: Hope in a Gathering Storm (1996)
  • The Children’s Vaccine Initiative: Continuing Activities (1995)
  • Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality (1994)
  • DPT Vaccine and Chronic Nervous System Dysfunction: A New Analysis (1994)
  • Research Strategies for Assessing Adverse Events Associated with Vaccines: A Workshop Summary (1994)
  • The Children’s Vaccine Initiative: Achieving the Vision (1993)
  • Adverse Effects of Pertussis and Rubella Vaccines (1991)
  • The Potential Value of Research Consortia in the Development of Drugs and Vaccines Against HIV Infection and AIDS (report of a workshop) (1989)
  • An Evaluation of Poliomyelitis Vaccine: Policy Options (1988)
  • Prospects for Vaccines Against HIV Infection (1988)
  • Temperature-Stable Vaccines for Developing Countries: Significance and Development Strategies (1987)
  • New Vaccine Development: Establishing Priorities. Volume II, Diseases of Importance in Developing Countries (1986)
  • New Vaccine Development: Establishing Priorities. Volume I, Diseases of Importance in the United States (1985)
  • Vaccine Supply and Innovation (1985)
  • Evaluation of Poliomyelitis Vaccines (1977)


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement